Name: Buy Cagrilintide 5mg in South Africa | BestPeptides™
Price: 3150.00 ZAR
Availability: OutOfStock

Cagrilintide 5mg

R3150,00

Cagrilintide 5mg is a novel peptide therapeutic designed to assist in weight management and obesity treatment. It works by mimicking the effects of the hormone amylin, which helps regulate appetite and promote feelings of fullness, leading to reduced caloric intake. This product is intended for use in adults as part of a comprehensive weight loss plan that includes a healthy diet and regular exercise.

Out of stock

Description

Cagrilintide 5mg is an innovative peptide-based medication developed for the management of obesity and overweight conditions. As a next-generation therapeutic, it targets the physiological mechanisms that regulate hunger and satiety, providing a comprehensive approach to weight loss. This medication is formulated to complement lifestyle interventions such as diet and exercise, making it a valuable tool for individuals who struggle to achieve significant weight loss through traditional methods alone.

Cagrilintide 5mg – Mechanism of Action

Cagrilintide works by mimicking the action of the hormone amylin, which is naturally produced in the pancreas. Amylin plays a crucial role in controlling appetite by slowing gastric emptying, reducing food intake, and promoting a sense of fullness after eating. By activating amylin receptors in the brain, Cagrilintide helps to decrease appetite and reduce overall caloric intake. This targeted action makes it particularly effective in supporting weight loss efforts, especially when combined with other weight management strategies.

Cagrilintide – Usage and Administration

Cagrilintide 5mg is administered via subcutaneous injection, typically once daily. The dosage and duration of treatment should be determined by a healthcare professional based on individual patient needs and response to therapy. It is essential to use this medication as part of a comprehensive weight loss plan that includes dietary changes and increased physical activity. Regular monitoring of progress and potential side effects is recommended to ensure optimal results. Cagrilintide 5mg is intended for use in adults with a body mass index (BMI) of 30 or greater, or in those with a BMI of 27 or greater who have at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.